Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 2446 AL 2460

Arbutin as a therapeutic candidate for autism: Current evidence and mechanistic insights into PI3K/Akt/mTOR and Nrf2 pathways

Abhishek, Singh S.

Eur J Pharmacol. 2026 Jul 15;1030:179103. doi: 10.1016/j.ejphar.2026.179103. Epub 2026 Jul 1.

Hyperkinetic manifestations in sporadic parkinsonism: An exploratory case series with APOE and NOS3 variants

Varanese S, Ferrante R, Buongarzone MP, Viola S, Fiorelli L, Travaglini D, Ajdinaj P, Speranza R, Bonanni L.

Clin Park Relat Disord. 2026 Jun 19;15:100474. doi: 10.1016/j.prdoa.2026.100474. eCollection 2026.

Epileptic-Dyskinetic Encephalopathy in Snijders Blok-Campeau Syndrome: Expanding the Phenotypic Spectrum

Manisha KY, Vijayaraghavan A, Rohith MG, Menon R, Krishnan S, Radhakrishnan A.

Mov Disord Clin Pract. 2026 Jul 2:10.1002/mdc3.70727. doi: 10.1002/mdc3.70727. Online ahead of print.

A convergence of global epidemics: diabetes as a modulator of neurodegenerative and neuro-inflammatory disorders

Leone L, Kiernan TJ, Kuwabara S, Barnett M, Devenney E, Ahmed RM, Lin CS.

Front Neurol. 2026 Jun 18;17:1824840. doi: 10.3389/fneur.2026.1824840. eCollection 2026.

Short CAG repeat variation as a regulatory factor in health and disease

Manjarrez JR.

Front Genet. 2026 Jun 19;17:1885864. doi: 10.3389/fgene.2026.1885864. eCollection 2026.

Mismatch repair dissection by in vivo RNAi reveals dose-dependent modulators of somatic instability and proteome remodeling in Huntington's disease

Belgrad J, Greco TM, Sapp E, Summers A, O'Reilly D, Luu E, Hutton JE, Yamada N, Fakih HH, Furgal R, Echeverria D, McHugh N, Bramato B, Furguson C, Hildebrand S, Allen S, Gaston N, Cooper D, Maebius A, Gross KY, Vogt TF, Finley M, Prasad B, DiFiglia M, Cristea IM, Aronin N, Khvorova A.

bioRxiv [Preprint]. 2026 Jun 24:2026.06.19.733435. doi: 10.64898/2026.06.19.733435.

The role of SUMOylation in regulating proteins that drive neuronal disease progression

Sidharth A, Shin D.

Biochem Biophys Rep. 2026 Jun 26;47:102687. doi: 10.1016/j.bbrep.2026.102687. eCollection 2026 Sep.

Neuroprotective potential of resveratrol in Parkinson, Huntington, amyotrophic lateral sclerosis, and multiple sclerosis: a comprehensive review

Shahsavari K, Yazarlu O, Ahmadnia H, Ardakani MT, Khanavi M, Esfahani HM, Abdollahzadeh R, Sajedi A, Kazemizadeh H, Hasanpour M.

Mol Biol Rep. 2026 Jul 4;53(1):1102. doi: 10.1007/s11033-026-12300-0.

Update on Genetic Chorea

Ostrozovicova M, Skorvanek M.

Curr Neurol Neurosci Rep. 2026 Jul 4;26(1):31. doi: 10.1007/s11910-026-01502-5.

Surgical Intervention for Posthyperglycemic Hemiballismus: Illustrative Case and Literature Review

Mani R, Kim T, Kim T, Uwakwe C, Zheng CY, Mofakham S, James E, Mikell C, Schwartz G.

Mov Disord Clin Pract. 2026 Oct;13(10):2586-2593. doi: 10.1002/mdc3.70728. Epub 2026 Jul 6.

Kynurenic Acid, a Key Endogenous Neuroprotective Agent: Role of Its Derivatives in Therapeutics

Verma S, Ambatwar R, Datusalia AK, Khatik GL.

ACS Chem Neurosci. 2026 Aug 5;17(15):2775-2801. doi: 10.1021/acschemneuro.6c00081.

Huntington's disease in the era of somatic instability, biomarkers, and targeted therapies: A narrative review

Cervantes-Arriaga A, Beltrán-Torres AX, Romero-García D, Rodríguez-Violante M.

Rev Invest Clin. 2026 Jul-Aug;78(4):100047. doi: 10.1016/j.ric.2026.100047. Epub 2026 Jul 7.

Effects of physical exercise on neurofilament light chain in multiple sclerosis and other neurological disorders: A systematic review

De León-Muñoz A, Rubio-Arias JÁ, Ávila-Gandía V, Andreu-Caravaca L.

Mult Scler Relat Disord. 2026 Sep;113:107357. doi: 10.1016/j.msard.2026.107357. Epub 2026 Jun 29.

SUMOylation in Mitochondrial Quality Control: Mechanisms and Implications for Neurodegenerative Disease

Wu Q, Fan D, Ren J, Xing Y, Chen Z, Jin H, Lu Y, Wang X, Zheng H.

Mol Neurobiol. 2026 Jul 10;63(1):753. doi: 10.1007/s12035-026-06050-0.

iPSC Neurodegenerative Disease Initiative isogenic CAG repeat iPSC line for Huntington's disease

Salazar L, Burns MS, Stocksdale JT, Wang KQ, Cao G, Miramontes R, McClure NR, Ho L, Keith AR, Sutherland M, Cookson MR, Ward M, Skarnes WC, Thompson LM.

bioRxiv [Preprint]. 2026 Jul 4:2026.06.30.735662. doi: 10.64898/2026.06.30.735662.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias